A Phase 3 interventional study of Misoprostol and Placebos in Contraception, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 44 Years. Per ClinicalTrials.gov, last updated 2018-12-31.
Sponsored by Ain Shams University · Phase 3, Interventional, and Treatment
the current study was conducted to assess efficacy of vaginal misoprostol before IUD insertion following previous insertion failure
Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
One previous failed attempt of IUD insertion.
Exclusion Criteria:
misoprostol (misotac® sigma pharmaceutical industries) 200 mcg vaginally applied ten and four hours prior to the second attempt of IUD insertion
Drug: Misoprostol
while the control group received a placebo tablet in the same regimen as the study group.
Drug: Placebos
vaginal misoprostol prior IUD insertion
vaginal placebo tablet prior IUD insertion
the success rate for IUD insertion.
the success of IUD insertion after previous attempt failure
Time frame: four hours after misoprostol dose
This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ain Shams University